Stock screener

BTMD

Conviction 55HealthcareScan · Thu, Jun 25, 2026
BTMD$1.95-7.14%
ResistanceSupportVol 14
63 bars
Vol MA14 237.34K
Mar 26Apr 14May 1May 19Jun 8Jun 25
biote Corp.MEDICINAL CHEMICALS & BOTANICAL PRODUCTSwww.biote.com
Price1.95
Change-7.14%
Gap+0.48%
Rel volume2.34×
Avg volume232.83K
Avg $ vol507.66K
SMA 202.21
SMA 502.16
SMA 2002.36
Price vs 50-9.72%
Price vs 200-17.24%
MA stackbearish
50/200 cross
Supertrenddown · 2.55
RSI (14)39
MACD hist-0.04
MACD crossbear · 4d
Stoch %K / %D1 / 10
ADX (14)14
+DI / −DI17 / 26
RSI divergence
MACD divergence
ATR %+8.02%
ADR %7.16%
52w high4.55
52w low1.30
From 52w high-57.14%
Above 52w low+50.00%
New 52w highNo
SqueezeOff
Bollinger width24.27%
%B0.01
Donchian pos3.51%
Donchian high2.50
Donchian low1.93
AVWAP (52w high)2.34
vs AVWAP high-16.55%
AVWAP (52w low)1.96
vs AVWAP low-0.68%
OBV trendDown
Chaikin MF (20)-0.11
Today vs 20d2.34×
Avg vol (14d)237.34K
Avg vol (20d)232.83K
Avg $ vol (20d)507.66K
Market cap113.53M
RS 3m (vs SPY)+30.60%
RS 6m (vs SPY)-32.20%
RS line new highNo
Trend template2/8
Technical rank19.0
1 week-14.10%
1 month+1.56%
3 months+35.42%
6 months-29.86%
1 year-51.13%
YTD-21.05%
P/E4.20
P/B-2.02
P/S0.59
P/FCF3.76
EPS0.7400
Div yield1.52%
ROE-48.22%
ROA30.38%
Debt/Eq-1.79
Current1.29
EV/EBITDA5.33
Gross margin
Net margin14.07%
Rev growth-2.52%
EPS growth756.67%
Price target
Target upside
Analyst rating
Institutional
Ent. value208.89M
Revenue44.94M
Net income2.28M
Gross profit
Free cash flow30.18M
IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS
ExchangeNasdaq
Shares out30.33M
Employees223
ListedFri, May 27, 2022
Free float14.96M
Float %46.4%
Short interest1.41M
Days to cover6.2d
Short volume36.5%
Squeeze score59 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast$0.07 · 1 est
Last EPS vs est
Last surprise
Setup gradeC
Conviction55 / 100
Pattern quality
Tech rank19.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance2.45
Support1.87
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BTMD

All disclosures →
No recent disclosed trades by Congress in BTMD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BTMD · 9 buys · 1 sell

InsiderSideShares
Christensen Bret
Director · Stock Option (Right to Buy) · 2026-06-08
Grant130K
Beer Marc D
Executive Chairman · Employee Stock Option (Right to Buy) · 2026-06-08
Grant114.16K
HEYER ANDREW R
Director · Deferred Settlement RSU · 2026-05-12
Grant35.26K
HEYER ANDREW R
Director · Stock Option (Right to Buy) · 2026-05-12
Grant130K
MORRIS DEBRA L
Director · Class A Common Stock · 2026-05-12
Exercise21.41K
Cone Stephen Mark
Director · Deferred Settlement RSU · 2026-05-12
Grant31.48K
Jacoby Dana Lynn
Director · Deferred Settlement RSU · 2026-05-12
Grant37.78K
Cone Stephen Mark
Director · Stock Option (Right to Buy) · 2026-05-12
Grant130K
Barrera Richard R
Director · Stock Option (Right to Buy) · 2026-05-12
Grant121.45K
MORRIS DEBRA L
Director · Deferred Settlement RSU · 2026-05-12
Exercise21.41K

SEC filings

EDGAR filings in BTMD · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.